Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OptiNose Inc OPTN

Healthcare
OptiNose, Inc. is a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists. The Company's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and... see more

Recent & Breaking News (NDAQ:OPTN)

Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference

GlobeNewswire December 7, 2017

Optinose Reports Third Quarter 2017 Financial Results and Recent Operating Highlights

GlobeNewswire November 27, 2017

Optinose to Report Third Quarter 2017 Financial Results and Operational Highlights on November 27, 2017

GlobeNewswire November 20, 2017

Optinose to Present at Piper Jaffray Healthcare Conference

GlobeNewswire November 17, 2017

Optinose to Present at Jefferies 2017 London Healthcare Conference

GlobeNewswire November 8, 2017

Optinose Expands Leadership Team with Key Hires

GlobeNewswire October 30, 2017

Optinose (Nasdaq: OPTN) to Ring The Nasdaq Stock Market Opening Bell

GlobeNewswire October 24, 2017

Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock

GlobeNewswire October 17, 2017